| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.21 | 2e-09 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.2 | 3e-09 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.2 | 7e-09 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.2 | 9e-09 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-08 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.16 | 7e-08 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-07 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-07 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-07 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-07 |